Lazard Transactions


DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided

Clear all Clear

Download results

Showing 11 to 20 of 5881 Results

May 27, 2026
Italy

Artsana (Investindustrial-backed), has completed a comprehensive review of its capital structure including €415m financial debt refinancing and €258m shareholder equity support

$782.8 Million

May 26, 2026
United States

Trinseo Takes Next Step to Implement Restructuring Support Agreement and Strengthen Financial Foundation

$3.1 Billion

May 26, 2026
United States

Vaccine Company to be acquired by Lilly to advance best-in-class vaccine candidates for Epstein-Barr Virus and other infectious diseases

$1.5 Billion

May 25, 2026
Brazil, France

Frances Loxam to buy controlling stake in Brazils Mills

$1 Billion

May 22, 2026
Netherlands

KNDS ANNOUNCES THE SUCCESSFUL SALE OF RENK SHARES

$304.9 Million

May 21, 2026
United Kingdom, United States

Sun Communities, Inc. Announces Agreement To Sell UK Assets For Approximately $1.03 Billion In An All-Cash Transaction

$1 Billion

May 21, 2026
France

Lazard acted as exclusive financial advisor to Kayrros on the sale of its defence activities to Safran.AI

Undisclosed

May 21, 2026
France, United Kingdom

Energy Aspects agrees to acquire Kayrros

Undisclosed

May 19, 2026
France

Lazard acted as Financial Advisor to DomusVi on its €500m inaugural bond issuance, €1,500m TLB refinancing and EUR289m RCF refinancing and upsize

$2.6 Billion

May 19, 2026
United States

Lilly to Acquire Orna Therapeutics to Advance Cell Therapies

$2.4 Billion